TABLE 2.

Allergan Chin Retrusion Scale Results at Month 6 (Modified Intent-to-Treat Population)

	Treatment (N = 144)	Control (N = 48)
Month 6
Total participants, n*	126	40
Responder, n (%)	71 (56.3)	11 (27.5)
Nonresponder, n (%)	55 (43.7)	29 (72.5)
95% CI (%)†	(47.23–65.16)	(14.60–43.89)
Versus control
Responder rate difference, %	28.85
95% CI (%)‡	11.16–45.60
p-value§	0.0019

For the untreated control group, data before receiving initial treatment at Month 6 are included.

^*Participants with analysis values at baseline and the specified visit.

^†95% CI is based on the exact binomial distribution.

^‡95% exact CI for the responder rate difference is presented.

^§p-value is based on 2-sided Fisher's exact test comparing the responder rate between treated and untreated control.